Dr. Riddhijyoti Talukdar

Dr. Riddhijyoti Talukdar is a Consultant Radiation Oncologist at HCG Cancer Centre, Borivali, Mumbai, with 8 years of experience. He specializes in advanced radiation techniques like IMRT, IGRT, and VMAT, and is skilled in both frame-based and frameless stereotactic radiosurgery and stereotactic body radiation therapy. Dr. Talukdar’s primary area of interest is Neuro-Oncology, Gynaecology and Head Neck Cancers, but he is also trained in treating Haematolymphoid, Breast, gastrointestinal and Urological malignancies. He is MBBS and DNB in Radiation Oncology and has worked as a Senior Research Fellow in Neuro-Oncology at Tata Memorial Centre, Mumbai. He has also done his Senior Residency at Tata Memorial Hospital, Mumbai.

·Talukdar, R., Epari, S., Sahay, A., Choudhari, A., Dasgupta, A., Chatterjee, A., Gupta,T., 2021. Endolymphatic sac tumor: single‑institution series of seven cases with an updated review of the literature.  European Archives of Oto-Rhino-Laryngology, Published Online 19th August, 2021, DOI: https://doi.org/10.1007/s00405-021-07047-2

·Tejpal Gupta, Riddhijyoti Talukdar, Sadhana Kannan, Archya Dasgupta, Abhishek Chatterjee, Vijay Patil, Efficacy and safety of extended adjuvant temozolomide compared to standard adjuvant temozolomide in glioblastoma: Updated systematic review and meta-analysis, Neuro-Oncology Practice, Volume 9, Issue 5, October 2022, Pages 354–363, https://doi.org/10.1093/nop/npac036

·R. Talukdar, A. Dasgupta, A. Chatterjee, A. Mishra, O. Roy Chowdhury, K.J. Joshi, A. Sutar, J. Sastri Goda, R.Krishnamurthy, T. Wadasadawala, R. Pathak, P. Maitre, V. Murthy, A. Gupta, P. Mittal, S. Chopra, A. Tibdewal, N.Mummudi, V. Singh, P. Shetty, A. Moiyadi, R. Kinhikar, R. Sarin, J. Agarwal, T. Gupta. (2023). Factors influencing set up margins for image guided frameless stereotactic radiosurgery. Radiotherapy and Oncology, Volume 182 Supplement 1, p.932-933.

·H. Bhosale, N. Hanumanthappa, S. Basu, P. Chadha, S. Karmakar-Mangaj, A. Srivastava, R. Talukdar, S. Nayak, P. Pawar, A. P.S., J. E.P., S. Pilakkal, K. Bist, M. Nadkarni, B. Ghugare, S. Goyle, I.N. Shaikh, R. Mistry. (2023). Post pandemic ultra-hypofractionated radiation in breast cancer from a tertiary Institution in India. Radiotherapy and Oncology, Volume 182 Supplement 1, p.1042-1043.

·Talukdar Riddhijyoti, Chatterjee Abhishek, Dasgupta Archya, Kannan Sadhana, Gupta Tejpal. (2022). Efficacy and safety of extended adjuvant temozolomide (>6-cycles) compared to standard 6-cycles of adjuvant temozolomide in newly diagnosed glioblastoma: Systematic review and meta-analysis of randomised controlled trials. Brain Tumour Research and Treatment, Supplement, S165. DOI: 10.14791/btrt.2022.10.F-1256

·Mukherjee, M., Bhattacharya, J., Shahid, T., Kontham, V., Rajan, R., Talukdar, R. and De, A., 2018. Re-Irradiation in Recurrent Gliomas: Treatment outcome and Prognostic factors. Radiotherapy and Oncology, Volume 133 Supplement 1, p.S675.

·Mukherjee, M., Shahid, T., Samanta, A., Biswas, L.N., Jawade, A., De, A., Barman, D., Ghosh, T., Sadhukhan, S., Vijayaraghavan, P., Talukdar, R., Saikia, C., Rajan, R., Raj, R., 2019. Comparative study assessing QoL in HNSCC patients treated with Radical Radiation with IMRT vs 3DCRT. Radiotherapy & Oncology, Volume 133 Supplement 1, p.S652.

·Bhattacharya, J., Jawade, A., Vijayaraghavan, P., Shahid, T., Mukherjee, M., Talukder, R., Samanta, A., Saikia, C., De, A., Barman, D., Ghosh, T. and Sadhukhan, S., 2018. Comparison of patient and physician reported acute toxicities during head and neck cancer radiotherapy. Radiotherapy & Oncology, Volume 133 Supplement 1, p.S651.

·Shahid, T., Kalyani, N., Modak Das, S., Mukherjee, M., Bhattacharya, J., De, A., Talukdar, R., Samanta, A., Ghosh, T., Barman, D., Sadhukan, S., Vijayaraghavan, P. and Rajan, R., 2019. To compare outcome of Intensive nutritional support with standard practise in head and neck cancer. Radiotherapy & Oncology, Volume 133 Supplement 1, p.S642.

·Bhattacharya, J., Mukherjee, M., Shahid, T., Rajan, R., Talukdar, R., S, J., Samanta, A. and Vijayaraghavan, P., 2018. Hypofractionated RT in Breast Cancer: Early Experience from a tertiary care centre in India. Radiotherapy & Oncology, Volume 127 Supplement 1, p.S723.

·Talukdar, R., Biswas, L., Bhattacharya, J., Mukherjee, M., Rajan, R., Samanta, A., Vijayaraghavan, P. and Shahid, T., 2018. Hypofractionated radiotherapy in breast cancer: Outcome of prospective study done in our institution. Journal of Cancer Research and Therapeutics, Volume 14(Supplement Issue 4), p.S827.

·Talukdar, R., Khan, E., Shahid, T., Sharma, P., Panja, S., Mukherjee, M., Bhattacharya, J., Vijayaraghavan, P. and Saikia, C., 2018. Epithelloid haemangioendothelioma of maxillary sinus: a rare case report. Journal of Cancer Research and Therapeutics, Volume 14(Supplement Issue 4), p.S919.

·Vijayaraghavan, P., Jawade, A., Mukherjee, S., Bhattacharya, J., Samanta, A., Talukdar, R. and Shahid, T., 2018. A prospective study to compare patient reported outcome measures and physician reported acute toxicities in patients treated with concurrent chemoradiation for locally advanced head and neck squamous cell carcinoma. Journal of Cancer Research and Therapeutics, Volume 14(Supplement Issue 4), p.S880.

·Samanta, A., Biswas, L., Bhattacharya, J., Mukherjee, M., Jawade, A., Talukdar, R., Vijayaraghavan, P., Shahid, T., Barman, D., De, A., Rajan, R., Raj, R. and Saikia, C., 2018. A prospective comparative study of quality-of-life outcomes in patients with head and neck squamous cell carcinoma treated with intensity modulated radiotherapy versus 3-dimensional conformal radiotherapy. Journal of Cancer Research and Therapeutics, Volume 14(Supplement Issue 4), p.S880.